These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 30153144)

  • 1. Impact of DAT-SPECT on Management of Patients Suspected of Parkinsonism.
    Mirpour S; Turkbey EB; Marashdeh W; El Khouli R; Subramaniam RM
    Clin Nucl Med; 2018 Oct; 43(10):710-714. PubMed ID: 30153144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of 123I-FP-CIT-SPECT in the differential diagnosis of Parkinson and tremor syndromes: a critical assessment of 125 cases.
    Sixel-Döring F; Liepe K; Mollenhauer B; Trautmann E; Trenkwalder C
    J Neurol; 2011 Dec; 258(12):2147-54. PubMed ID: 21547379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
    Appel L; Jonasson M; Danfors T; Nyholm D; Askmark H; Lubberink M; Sörensen J
    J Nucl Med; 2015 Feb; 56(2):234-42. PubMed ID: 25593112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine transporter single photon emission computed tomography (DaT-SPECT) use in the diagnosis and clinical management of parkinsonism: an 8-year retrospective study.
    Tsang K; Walker R
    J Neurol; 2023 May; 270(5):2550-2558. PubMed ID: 36795149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of the combination of a SPECT study with [123I]-FP-CIT of dopamine transporters and [123I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes.
    Uyama N; Otsuka H; Shinya T; Otomi Y; Harada M; Sako W; Izumi Y; Kaji R; Watanabe Y; Takashi S; Kunikane Y
    Nucl Med Commun; 2017 Jun; 38(6):487-492. PubMed ID: 28410288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DAT-SPECT imaging in cases of drug-induced parkinsonism in a specialty movement disorders practice.
    Yomtoob J; Koloms K; Bega D
    Parkinsonism Relat Disord; 2018 Aug; 53():37-41. PubMed ID: 29748111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burden of non-motor symptoms in unclear parkinsonism and tremor: A study with [
    Jaakkola E; Joutsa J; Mäkinen E; Noponen T; Pitkonen M; Levo R; Mertsalmi T; Scheperjans F; Kaasinen V
    J Neurol Sci; 2019 Sep; 404():124-127. PubMed ID: 31374410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: a 2-year follow-up multicenter study.
    Tinazzi M; Morgante F; Matinella A; Bovi T; Cannas A; Solla P; Marrosu F; Nicoletti A; Zappia M; Luca A; Di Stefano A; Morgante L; Pacchetti C; Minafra B; Sciarretta M; Dallocchio C; Rossi S; Ulivelli M; Ceravolo R; Frosini D; Cipriani A; Barbui C
    Schizophr Res; 2014 Feb; 152(2-3):344-9. PubMed ID: 24369987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice.
    Ba F; Martin WR
    Parkinsonism Relat Disord; 2015 Feb; 21(2):87-94. PubMed ID: 25487733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is There a Role for DAT-SPECT Imaging in a Specialty Movement Disorders Practice?
    Bega D; Gonzalez-Latapi P; Zadikoff C; Spies W; Simuni T
    Neurodegener Dis; 2015; 15(2):81-6. PubMed ID: 25592727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of DAT-SPECT in movement disorders.
    Kägi G; Bhatia KP; Tolosa E
    J Neurol Neurosurg Psychiatry; 2010 Jan; 81(1):5-12. PubMed ID: 20019219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropathologic Validation and Diagnostic Accuracy of Presynaptic Dopaminergic Imaging in the Diagnosis of Parkinsonism.
    Hastings A; Cullinane P; Wrigley S; Revesz T; Morris HR; Dickson JC; Jaunmuktane Z; Warner TT; De Pablo-Fernández E
    Neurology; 2024 Jun; 102(11):e209453. PubMed ID: 38759132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Referral practice, reporting standards, and the impact of dopamine transporter scans done in a tertiary hospital.
    Bhattacharjee S; Chalissery AJ; Barry T; O'Sullivan D; O'Connell M; Lynch T
    Neurol India; 2017; 65(6):1264-1270. PubMed ID: 29133699
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Yang HJ; Park SH; Seo M; Weon YC; Kim Y
    Neurotoxicology; 2018 Jan; 64():78-84. PubMed ID: 28259768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia.
    Jeon BS; Jeong JM; Park SS; Kim JM; Chang YS; Song HC; Kim KM; Yoon KY; Lee MC; Lee SB
    Ann Neurol; 1998 Jun; 43(6):792-800. PubMed ID: 9629849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of Follow-up Dopamine Transporter SPECT With 123I-FP-CIT in the Diagnostic Workup of Patients With Clinically Uncertain Parkinsonian Syndrome.
    Apostolova I; Taleb DS; Lipp A; Galazky I; Kupitz D; Lange C; Makowski MR; Brenner W; Amthauer H; Plotkin M; Buchert R
    Clin Nucl Med; 2017 Aug; 42(8):589-594. PubMed ID: 28574876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep learning regressor model based on nigrosome MRI in Parkinson syndrome effectively predicts striatal dopamine transporter-SPECT uptake.
    Bae YJ; Choi BS; Kim JM; Ai WA; Yun I; Song YS; Nam Y; Cho SJ; Kim JH
    Neuroradiology; 2023 Jul; 65(7):1101-1109. PubMed ID: 37209181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and 123I-FP-CIT SPECT imaging in vascular parkinsonism and Parkinson's disease.
    Benítez-Rivero S; Marín-Oyaga VA; García-Solís D; Huertas-Fernández I; García-Gómez FJ; Jesús S; Cáceres MT; Carrillo F; Ortiz AM; Carballo M; Mir P
    J Neurol Neurosurg Psychiatry; 2013 Feb; 84(2):122-9. PubMed ID: 22906618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic neuronal integrity in parkinsonism associated with liver cirrhosis.
    Kim JM; Kim JS; Jeong SH; Kim YK; Kim SE; Kim SH; Kim Y
    Neurotoxicology; 2010 Aug; 31(4):351-5. PubMed ID: 20457180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual versus automated analysis of [I-123]FP-CIT SPECT scans in parkinsonism.
    Mäkinen E; Joutsa J; Johansson J; Mäki M; Seppänen M; Kaasinen V
    J Neural Transm (Vienna); 2016 Nov; 123(11):1309-1318. PubMed ID: 27324804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.